A mysterious case of Dr Cabot
Double minutes with MYC amplification in a patient with chronic myelomonocytic leukaemia transformed into acute myeloid leukaemia
How I manage heavy menstrual bleeding
Splanchnic vein thrombosis in myeloproliferative neoplasms
Catheter-related thrombosis in cancer patients
Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO
Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups
Disseminated lymphoblastic lymphoma in children and adolescents: results of the COG A5971 trial: a report from the Children's Oncology Group
Anti-leukaemic activity of a novel haploidentical-transplantation approach employing unmanipulated bone marrow followed by CD6-depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemia
Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft-versus-host disease?
Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels
Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients
Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease
The induction of immunogenic cell death by type II anti-CD20 monoclonal antibodies has mechanistic differences compared with type I rituximab
Pegylated liposomal doxorubicin: an efficient treatment in patients with Hodgkin lymphoma relapsing after high dose therapy and stem cell transplation
BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia
Novel compound VHL heterozygosity ( VHL T124A/L188V) associated with congenital polycythaemia
Haematological recovery in dyskeratosis congenita patients treated with danazol
Clinical profile and treatment outcomes of immunoglobulin D associated AL amyloidosis
X chromosome-wide association study of follicular lymphoma
Announcement
Corrigendum